Pharmacy Clinical Pearl of the Day: Aldosterone Blockers and Hyperkalemia

Article

Aldosterone blockers, such as spironolactone and eplerenone, can cause hyperkalemia.

Aldosterone blockers, spironolactone (Aldactone) and eplerenone, can cause hyperkalemia.

When hyperkalemia occurs, the medications that can be used in reducing K levels are:

  • Patiromer (Veltassa)
  • Lokelma (Sodium zirconium cyclosilicate)

Explanation

Both spironolactone (Aldactone) and eplerenone, when started, can potentially increase potassium levels and cause hyperkalemia. Therefore, dosing for these medications is always dependent of the potassium levels:

Spironolactone

  • If GFR≥50 ml/min, K+<5, start 12.5-25 mg daily, then increase to 25 mg BID if K<5, after 4 weeks.
  • If GFR 30-49 ml/min, 12.5 daily or QOD and increase to 12.5 to 25 mg daily.

Eplerenone

  • For GFR≥50 ml/min, start 25 mg daily and increase to 50 mg daily.
  • If GFR 30-49 ml/min, 25 mg QOD and increase to 25 mg daily.
Recent Videos
Image Credit: © pixelrobot- stock.adobe.com
Public Health Matters podcast logo
Image Credit: © Beaunitta Van Wyk/peopleimages.com - stock.adobe.com
Virtual Reality for Pharmacy School | Image Credit: toxicoz - stock.adobe.com
Covid-19 Vaccine New Variant 2024-2025 | Image Credit: New Africa - stock.adobe.com
Pharmacy students, university, assignment, tiktok | Image Credit: .shock - stock.adobe.com
Pharmacy Students in Lab, TikTok | Image Credit: D Lahoud/peopleimages.com - adobe.stock.com
Medical students listening to a lecture in the lab - Image credit:  luckybusiness | stock.adobe.com
Social Media Learning Pharmacy Students | Image Credit: Rawpixel.com - stock.adobe.com
COVID-19 vaccine 2024-2025 Season | Image Credit: Alernon77 - stock.adobe.com